Castration Resistant Prostate Cancer Crpc Therapeutics Market Size And Share

  • Report Code : TIPRE00016400
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

거세 저항성 전립선암(CRPC) 치료제 시장 점유율 분석 및 기회 [2025-2031]

Buy Now

Castration-Resistant Prostate Cancer (CRPC) Therapeutics Market Report Castration-Resistant Prostate Cancer (CRPC) Therapeutics Market Scope and Analysis Castration-Resistant Prostate Cancer (CRPC) Therapeutics Market Size and Share

Castration-Resistant Prostate Cancer (CRPC) Therapeutics Market Report Analysis

Castration-Resistant Prostate Cancer (CRPC) Therapeutics Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Bayer AG
  • AbbVie Inc.
  • Johnson and Johnson
  • Sanofi
  • Amgen Inc.
  • Novartis AG
  • OncoGenex Technologies Inc.
  • Pfizer Inc.
  • GlaxoSmithKline plc

Regional Overview

  • 북미
  • 유럽
  • 아시아 태평양
  • 중남미
  • 중동 및 아프리카

Market Segmentation

By 치료
  • 화학요법
  • 호르몬요법
  • 면역요법
  • 방사선요법
By 투여경로
  • 주사제
  • 경구
By 유통채널
  • 병원 및 소매약국
  • 온라인 유통
By 지리
  • 북미
  • 유럽
  • 아시아 태평양
  • 중남미